Literature DB >> 15893844

A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis.

Marco Domenicali1, Paolo Caraceni, Alessandro Principe, Anna Maria Pertosa, Josefa Ros, Pasquale Chieco, Franco Trevisani, Wladimiro Jiménez, Mauro Bernardi.   

Abstract

BACKGROUND/AIMS: We aimed to develop a non-invasive test to identify the initial alterations of sodium homeostasis and prospectively predict decompensation in preascitic cirrhotic rats.
METHODS: The sodium overload test (SOT) was performed in control (CT) and CCl4-induced cirrhotic rats (CH) by calculating the percentage of sodium excreted in the urine after NaCl oral administration (0.5 g/kg). Liver fibrosis was quantified by image cytometry.
RESULTS: From the 8th week of CCl4 intoxication, while the daily sodium balance did not change in CH and CT, SOT became significantly lower in the former (62.1+/-13.2 vs 78.8+/-13.2%; P=0.035). At sacrifice, ascites was only present in one animal. The degree of liver fibrosis correlated with SOT. In subsequent experiments, 17 cirrhotic rats developed ascites between the 9th and 14th weeks. SOT remained stable up to 3 weeks before ascites appearance, while it fell significantly to 35+/-19 and 26+/-21% at 2 and 1 week before ascites diagnosis, respectively. Nearly all the rats (95%) with a SOT<60% developed ascites within 3 weeks.
CONCLUSIONS: In preascitic cirrhotic rats, SOT unveils sodium metabolism abnormalities earlier than the daily sodium balance and prospectively predicts ascites appearance, identifying rats in a homogeneous stage of cirrhosis, which is essential in pathophysiological studies on sodium retention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15893844     DOI: 10.1016/j.jhep.2005.01.034

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  5 in total

Review 1.  Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma.

Authors:  Samuele De Minicis; Tatiana Kisseleva; Heather Francis; Gianluca Svegliati Baroni; Antonio Benedetti; David Brenner; Domenico Alvaro; Gianfranco Alpini; Marco Marzioni
Journal:  Dig Liver Dis       Date:  2012-11-22       Impact factor: 4.088

2.  HBP1-mediated transcriptional repression of AFP inhibits hepatoma progression.

Authors:  Zhengyi Cao; Yuning Cheng; Jiyin Wang; Yujuan Liu; Ruixiang Yang; Wei Jiang; Hui Li; Xiaowei Zhang
Journal:  J Exp Clin Cancer Res       Date:  2021-04-01

3.  Adaptive Mechanisms of Renal Bile Acid Transporters in a Rat Model of Carbon Tetrachloride-Induced Liver Cirrhosis.

Authors:  Chiara Donadei; Andrea Angeletti; Maria Cappuccilli; Massimiliano Conti; Diletta Conte; Fulvia Zappulo; Alessio De Giovanni; Deborah Malvi; Rita Aldini; Aldo Roda; Gaetano La Manna
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

4.  Effect of a diet with unrestricted sodium on ascites in patients with hepatic cirrhosis.

Authors:  Xi-Bing Gu; Xiao-Juan Yang; Hong-Ying Zhu; Bo-Yu Xu
Journal:  Gut Liver       Date:  2012-07-12       Impact factor: 4.519

5.  A mouse model of subacute liver failure with ascites induced by step-wise increased doses of (-)-epigallocatechin-3-gallate.

Authors:  Xiaoxiao Wang; Lumin Yang; Jiajia Wang; Yafei Zhang; Ruixia Dong; Ximing Wu; Chung S Yang; Zhenhua Zhang; Jinsong Zhang
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.